What's new?

Recent CRM news and press releases.

MS research points towards treatments to repair damaged nerves

Embargoed until (GMT): 
21 Jul 2013 - 6:00pm UTC

Oligodendrocytes (green, left) start making myelin (red, right) when exposed to Activin A.Oligodendrocytes (green, left) start making myelin (red, right) when exposed to Activin A.

Multiple sclerosis treatments that repair damage to the brain could be developed thanks to new research.

A study has shed light on how cells are able to regenerate protective sheaths around nerve fibres in the brain.

Transatlantic partnership to tackle neurodegenerative disease

Embargoed until (GMT): 
18 Jul 2013 - 2:02pm UTC

Research into multiple sclerosis and motor neurone disease is to be boosted with an international collaboration to further understanding of these illnesses.

Experts from the University of Edinburgh and the Massachusetts-based biotechnology company Biogen Idec will work together to seek greater insight into the cell processes behind these debilitating conditions.

This will include identifying drug compounds that could potentially be used as treatments.

SCRM building wins New Laboratory Building of the Year award

The Scottish Centre for Regenerative Medicine (SCRM) building has been named as best new laboratory building in the S-Lab Awards, which recognise laboratories for sustainability, safety and success.

Stem cells reach standard for use in drug development

Embargoed until (GMT): 
11 Jun 2013 - 9:32am UTC

Drug development for a range of conditions could be improved with stem cell technology that helps doctors predict the safety and the effectiveness of potential treatments.

Medical Research Council scientists at the University of Edinburgh have been able to generate cells in the laboratory that reach the gold standard required by the pharmaceutical industry to test drug safety.

Licences granted for manufacture of human cell therapy products

Embargoed until (GMT): 
31 May 2013 - 1:00am UTC

Roslin Cells Ltd, the Scottish National Blood Transfusion Service (SNBTS) and the University of Edinburgh announced today that the GMP Cellular Therapy Manufacturing Facility within the Scottish Centre for Regenerative Medicine (SCRM) has recently been licensed by the Medicines and Healthcare products Regulatory